Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests a breathing exerciser device in adults with lung conditions

Tests a home breathing device in people with shortness of breath, COPD or asthma.

Plain-language title generated from the registry record
Registry title: The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)

Key facts

Where
Omaha, United StatesSee the site

Where in United States

  • Biomechanics Research BuildingOmaha, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Nebraska
Trial code
NCT06524856
Record updated
19 October 2026
Original description
Investigators are studying how a device called The Lung Master device can help people breathe better. The investigational device increases the amount of air our lungs can hold, which is important for overall lung health. The Lung Master is not approved by the FDA.Read full original descriptionShow less

The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)

Investigators are studying how a device called The Lung Master device can help people breathe better. The investigational device increases the amount of air our lungs can hold, which is important for overall lung health. The Lung Master is not approved by the FDA.

The study has two visits approximately one month apart. In the first visit participants will take a spirometry test, particularly forced vital capacity (FVC), to measure volume change in the lungs. Participants will take the investigational device home to use daily, either in the morning or evening. Use will be recorded in a diary. After one month, participants will return for another spirometry test. Each study visit will take about one to two hours to complete.

Inclusion: able to complete the at home portion of the study daily; fall within the age ranges: 19-35 and above 65 years old.

Exclusion: any respiratory or chronic conditions.

ClinicalTrials.gov NCT06524856